Profile

    Corporate information

    Official name
    Alexion Pharmaceuticals Incorporated

    Registration country
    Investment activity status
    Active investor

    Company type

    Complement inhibition for cardiovascular and inflammatory diseases.

    Funding rounds


    Profile Country Notes
    CHL Medical Partners Venture capital firm focused on early-stage healthcare sectors. United States

    Current and past shareholders

    Investor Contacts Round
    CHL Medical Partners logo CHL Medical Partners
    Venture capital firm focused on early-stage healthcare sectors.
    +1 (203) 324-7700
    N/A

    Selected investments

    Country Date Notes
    Enobia Pharma Corp
    Canada 28 Dec 2011 Acquisition
    USD 1,100,000,000 (USD 1,100,000,000) deal size. Active
    Taligen Therapeutics Inc
    United States 31 Jan 2011 Acquisition
    USD 111,000,000 deal size.

    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.